With the cash outflow and lack of any kind of cash flow, profits, real contracts (or, indeed, real technology), I would suggest that it's not long now until this dog goes under 1 cent.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025